A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI) identified a mechanism driving neuroendocrine prostate cancer, a rare and highly aggressive subtype for which there currently are no effective treatment options. Findings published in Genes & Development show that prostate tumours in mice became more aggressive when the protein ERRγ was lost, while restoring its production in human cancer cells reversed this effect. Prostate cancer is the most commonly diagnosed cancer among men in Canada. Tumours that stop responding to hormone therapy evolve into neuroendocrine prostate cancer in about 15 per cent of patients, according to past research. After this shift, life expectancy typically falls below 18 months. “Therapy resistance remains one of the biggest challenges in cancer treatment, and prostate cancer is no exception,” said lead author Vincent Giguère, Professor in McGill’s Department of Biochemistry and GCI researcher. “Our findings highlight ERRγ as a promising new therapeutic target.” Existing drugs show promise when ERRγ is lost The researchers used advanced genetic and metabolic analysis to understand how losing ERRγ drives tumour growth. Their investigation revealed that two genes linked to cancer become overactive when ERRγ is missing. As drugs that block these genes already exist for other cancers, the team tested two of them in mouse and human prostate cancer cells. When combined, the two drugs slowed the cancerous growth far more effectively than either drug alone. “These findings have major clinical implications,” said Giguère. “By targeting the genes that take over when ERRγ activity is low or lost, we open the door to new treatment strategies for patients who currently have few options.” Understanding why ERRγ function becomes impaired in the first place is still being investigated, he added. Protein acts as brake on tumour progression ERRγ, previously known for its role in energy metabolism, appears to act as a brake that prevents prostate cancer from advancing. Preclinical findings led by first author Ting Li, a post-doctoral fellow in Giguère’s lab, have revealed that neuroendocrine prostate cancers have much lower levels of ERRγ than other types of prostate tumours. Removing the protein in mice sped up tumour progression, while reactivating the protein in human prostate cancer cells reversed the process, confirming its protective effect. About the study “ERRγ impedes neuroendocrine prostate cancer development” by Ting Li and Vincent Giguère et al., was published in Genes & Development. The study was conducted in collaboration with Prof. Jin-Jian Lu of the University of Macau and supported by the Canadian Institutes of Health Research, the Terry Fox Research Institute, the Cancer Research Society, Fonds de Recherche du Québec – Santé and Défi Canderel.

McGill University researchers at the Douglas Research Centre have found evidence that heavy cannabis use during pregnancy can cause delays in brain development in the fetus that persist into adulthood...

The company that makes Tylenol is pushing back against a proposed safety warning on labels for all drugs containing acetaminophen. A petition filed with the U.S. Food and Drug Administration calls for...

As respiratory virus season kicks off and COVID-19 cases continue to rise, provinces and territories are launching their vaccination campaigns. In Quebec, free vaccines will be available only to membe...

McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells. In a study published in Nature Communications, th...

Girls who overeat regularly in the preschool years are more likely to experience anxiety, impulsivity and hyperactivity in adolescence, according to a new study led by researchers at McGill University...

On Sept. 28, it will be five years since Joyce Echaquan, an Atikamekw woman, died in a hospital north of Montreal after having broadcast on Facebook racist and sexist remarks being made about her by h...

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study. Previous surveys sugge...

The Public Health Agency of Canada has released an updated list of priority pathogens – sometimes referred to as superbugs – that pose the greatest threat to Canadians. It’s the first update since 201...

The Canadian Medical Association is warning that science is under attack and false health information is spreading rapidly, with serious implications for public trust and patient health. A statement r...

Sept. 10 is World Suicide Prevention Day. A new World Health Organization report underscores the urgency of suicide prevention, estimating that 727,000 people died by suicide in 2021 alone. It is a le...

The Democratic Republic of Congo has reported its first Ebola outbreak in three years, which has already claimed 15 lives. McGill University experts are available to discuss concerns about the world’s...

Researchers at McGill University and the Douglas Institute have identified two specific types of brain cells that are altered in people with depression. The study, published in Nature Genetics, opens ...

How severely a person experiences tinnitus is shaped by their mood, sleep quality and even personality traits, a new study has found. Tinnitus is a persistent ringing or buzzing in the ears that affec...

A new study finds that a high-salt diet triggers brain inflammation that drives up blood pressure. The research, led by McGill University scientist Masha Prager-Khoutorsky in collaboration with an int...

Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training Artificial intelligence (AI) is becoming a powerful new tool in training and education...

Fragments of ancient viral DNA once dismissed as “junk” may play a role in controlling our genes, according to a new international study. Using a novel method to trace the evolutionary history of vira...

Researchers have shed new light on the most common genetic variant linked to hereditary cancer in Quebec’s French-Canadian population. Their findings could result in cheaper and more effective screeni...